Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Wilkison William, holds the title of Chief Scientific Officer at Vogenx, Inc..
On 2026-11-18, the insider transacted 5,900 shares.The shares were transacted at a weighted average price of $1.03 per share, resulting in a total market-relevant value of $6K.
Wilkison William (Chief Scientific Officer) exercised options for $6K of $VOGX
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.